↓ Skip to main content

Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, July 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
patent
13 patents

Readers on

mendeley
93 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, July 2012
DOI 10.2147/dmso.s27528
Pubmed ID
Authors

Helen Berlie, Kathryn M Hurren, Nicole R Pinelli

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 1%
Brazil 1 1%
Unknown 91 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 16%
Student > Master 13 14%
Student > Postgraduate 11 12%
Student > Ph. D. Student 10 11%
Student > Bachelor 7 8%
Other 21 23%
Unknown 16 17%
Readers by discipline Count As %
Medicine and Dentistry 45 48%
Pharmacology, Toxicology and Pharmaceutical Science 9 10%
Agricultural and Biological Sciences 8 9%
Nursing and Health Professions 4 4%
Biochemistry, Genetics and Molecular Biology 3 3%
Other 8 9%
Unknown 16 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 October 2019.
All research outputs
#2,710,799
of 25,756,911 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#131
of 1,192 outputs
Outputs of similar age
#16,647
of 177,408 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#3
of 10 outputs
Altmetric has tracked 25,756,911 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,192 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 10.0. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,408 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.